Showing results (101-110 of 119) with videos related to
Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|July 1, 1994
Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus diseaseM A Jacobson, J Gallant, L H Wang, et al.The Journal of Infectious Diseases|August 1, 1993
A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDSM A Jacobson, D Causey, B Polsky, et al.The American Review of Respiratory Disease|July 1, 1991
Morbidity and mortality of patients with AIDS and first-episode Pneumocystis carinii pneumonia unaffected by concomitant pulmonary cytomegalovirus infectionM A Jacobson, J Mills, J Rush, et al.The Journal of Infectious Diseases|June 1, 1995
Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: a phase I/II study. AIDS Clinical Trials Group, and Cytomegalovirus Cooperative Study GroupS A Spector, D F Busch, S Follansbee, et al.Clinical Pharmacology and Therapeutics|April 1, 1995
Foscarnet and ganciclovir pharmacokinetics during concomitant or alternating maintenance therapy for AIDS-related cytomegalovirus retinitisF T Aweeka, J G Gambertoglio, F Kramer, et al.The Journal of Infectious Diseases|February 1, 1994
Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDSM A Jacobson, C L Besch, C Child, et al.The New England Journal of Medicine|September 30, 1990
Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trialG S Leoung, D W Feigal, A B Montgomery, et al.AIDS (London, England)|April 1, 1994
Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious DiseasesM A Jacobson, M Wulfsohn, J E Feinberg, et al.The Journal of Infectious Diseases|July 1, 1994
Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical Trials Group Protocol 151M A Jacobson, F Kramer, Y Bassiakos, et al.The Journal of Infectious Diseases|December 1, 1994
Relationship between plasma concentrations of 3'-deoxy-3'-fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trialsC Flexner, C van der Horst, M A Jacobson, et al.Pageof 12